Form 4: USANA Director Timothy Wood's Stock Transactions
Insider Transaction Report
USANA Health Sciences Director Timothy Wood reported the acquisition of common stock through RSU vesting and a subsequent sale for tax purposes.
Summary
- Director Timothy E. Wood acquired 1,057 shares of USANA Health Sciences Inc. common stock on October 23, 2025, through the vesting of Restricted Stock Units (RSUs).
- Following the acquisition, Mr. Wood disposed of 265 shares of common stock at a price of $20.63 per share on the same date, likely for tax withholding related to the RSU vesting.
- After these transactions, Mr. Wood's direct beneficial ownership of common stock stands at 9,027 shares.
- Mr. Wood beneficially owns 2,115 Restricted Stock Units, which represent a contingent right to receive one share of USNA common stock per unit.
- The Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Sentiment
Score: 5
Explanation: The filing details routine insider transactions related to equity compensation, which is neither inherently positive nor negative for the company's immediate prospects.
Positives
- Director Timothy Wood received 1,057 shares of common stock through the vesting of Restricted Stock Units, indicating continued compensation and alignment with shareholder interests.
Negatives
- Director Timothy Wood disposed of 265 shares of common stock, reducing his direct beneficial ownership, although this was likely for tax withholding purposes related to the RSU vesting.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minor impact as the transaction is a routine insider compensation event and does not signal a significant change in company fundamentals or strategy.
- Employees (specifically Director Timothy Wood): The vesting of RSUs represents a realization of equity compensation, aligning the director's interests with long-term company performance.
Next Steps
- Future vesting of remaining Restricted Stock Units on January 22, 2026, and April 23, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | First 25% vesting date for Restricted Stock Units. |
| 10/23/2025 | Transaction date for acquisition of 1,057 common shares via RSU vesting and disposition of 265 common shares for tax withholding. |
| 10/23/2025 | Second 25% vesting date for Restricted Stock Units. |
| 10/27/2025 | Signature date of the reporting person's attorney-in-fact. |
| 01/22/2026 | Third 25% vesting date for Restricted Stock Units. |
| 04/23/2026 | Final 25% vesting date for Restricted Stock Units. |
Keywords
USANA Health Sciences, USNA, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Director Stock Sale, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.